Decheng Capital »

Tango Therapeutics shares owned by Decheng Capital

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Decheng Capital from 13F filings

Historical chart of Decheng Capital investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Decheng Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $625k 20k 31.26

More positions owned by Decheng Capital

Cg Oncology (CGON)
Nuvation Bio (NUVB)
Aardvark Therapeutics (AARD)
Aclaris Therapeutics (ACRS)
Upstream Bio (UPB)
Arcus Biosciences Incorporated (RCUS)
Equillium (EQ)
Revolution Medicines (RVMD)
Lyell Immunopharma
BeyondSpring SHS (BYSI)
Zentalis Pharmaceuticals (ZNTL)
Newamsterdam Pharma Co Nv (NAMS)
Pyxis Oncology (PYXS)
Tango Therapeutics (TNGX)

View all positions for Decheng Capital

Top funds holding Tango Therapeutics

Rtw Investments
BlackRock
FMR
Farallon Capital Management
Boxer Capital Management
Goldman Sachs Group
TCG Crossover Management
Trv Gp Iv
Paradigm Biocapital Advisors
Siren
Vanguard Capital Management
Adage Capital Partners GP
Jupiter Topco
State Street Corporation
Deep Track Capital

View all funds holding Tango Therapeutics